IPRIPR2016-01332Final Written Decision
Mylan Pharmaceuticals Inc. et al.v.Janssen Oncology, Inc. et al.
IPR challenge of US 8822438.
Type
IPR
Filed
Jun 30, 2016
Instituted
Jan 10, 2017
Decided
—
Patent
Application
13034340
Inventor
Alan H. Auerbach et al
Granted
Sep 2, 2014
01
Timeline
3 milestones
2016-06-30Petition filed
2017-01-10Institution
2018-01-17Terminated
02
Parties & counsel
Petitioner
Mylan Pharmaceuticals Inc. et al.
Counsel
White, Brandonet al
Patent Owner
Janssen Oncology, Inc. et al.
Counsel
Elderkin, Dianneet al
03
Docket
Documents are mirrored from the PTAB e-file system. Filer is as stated on the face of the filing.
SOURCE · USPTO PTAB E2EView on Unified Patents →